A cure for HIV would be one of the greatest medical achievements in modern history. But the day a cure is celebrated could also be the day some long-term survivors are told they no longer qualify for the benefits and services that have helped them stay alive.
In our work with long-term survivors, community advisory boards, and discussions about a cure, we have heard a recurring concern that deserves far more policy attention: What if a cure — or durable control, where the virus remains in the body, but at such low levels that it doesn’t cause problems and cannot be transmitted — is treated as proof that support for patients is no longer needed? That fear comes from people who want a cure, but are also wary about what can happen when administrative systems move faster than common sense.
HIV cure research has advanced enough that policymakers should prepare now for its social and administrative consequences, not only its scientific promise. Over the past decade, the field has moved from theory to increasingly sophisticated immunological, gene-based, and combination strategies. A handful of cases have shown that it may be possible to rid the body of HIV, or to reach a point where the virus stays dormant without daily medication.
